Clinical Trial

A Clinical Study on the Use of a Domestically Produced Three-dimensional Cardiac Electrophysiological Mapping System Combined With Pressure Monitoring Technology and Star Mapping Technology for the Treatment of Paroxysmal Atrial Fibrillation.

Study acronym: paroxysmal at
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Validating the safety and efficacy of pressure monitoring technology and star-shaped marking technology for the treatment of paroxysmal atrial fibrillation
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-18.
Trial Details
NCT Number NCT07039032
Lead Sponsor Shanghai MicroPort EP MedTech Co., Ltd.
Conditions Paroxysmal Atrial Fibrillation (PAF)
Enrollment 20 participants
Start Date 2025-09-30
Primary Completion 2025-09-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-27